Site Search
Professionals 174 results
Capabilities 52 results
Industry
Winston’s financial crimes compliance lawyers have been providing regulatory compliance counseling and enforcement services related to the Bank Secrecy Act (BSA), the Anti-Money Laundering Act of 2020 (AML), and countering the financing of terrorism (CFT) policy for decades. We also have experience with international AML matters, including in the EU and with respect to Financial Actions Task Force (FATF) recommendations.
Practice Area
Brands across key sectors turn to Winston litigators to defend their reputations in advertising class actions, competitor disputes, and investigations. With litigators based in the U.S.’s busiest jurisdictions—including courts in California, Florida, Illinois, New York, and Texas—we have deep experience and prowess in handling some of the most high-profile and business-essential advertising cases in recent history. These disputes have involved false advertising; unfair competition, unfair business practices, and unjust enrichment; copyright, trade name, and service mark infringement; consumer-protection claims; and violations of the Lanham Act.
Practice Area
Commercial Litigation & Disputes
Winston represents clients in virtually every type of dispute that could arise from operating a business. While our primary objective is to protect our clients from the need to engage in litigation and enter the courtroom, we take pride in our heavyweight litigation experience and the knowledge that corporate America has repeatedly retained us not just for “bet-the-company” trials, but for “bet-the-industry” cases as well. Our commercial litigators’ track record of success earned the team a national Tier 1 ranking in Best Law Firms® 2023. Our practice is anchored by seasoned litigators, many of whom have been recognized by in-house counsel and their peers as top practitioners in their fields.
Experience 7 results
Experience
|February 12, 2024
Experience
|March 31, 2023
Triumphed for Relevent Sports Before Second Circuit, Reviving Antitrust Suit Against FIFA, USSF
Insights & News 784 results
Client Alert
|May 1, 2025
|3 Min Read
April 2025 Executive Order Targets Prescription Drug Price Reduction
On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The subject matter of this executive order criss-crosses considerable policy ground in the overall U.S. pharmaceutical distribution chain. The executive order sets forth the administration’s statement of objectives to reduce prescription medication costs by promoting competition and eliminating practices that lead to high drug prices. Referencing regulatory and policy actions from the first Trump administration and the Biden administration’s policy steps, including the Inflation Reduction Act of 2022 aimed at lowering prescription drug prices for Medicare beneficiaries, the executive order sets forth a broad agenda to impact Medicare prescription drug costs, including in the Medicare Part D program.[1] The order directs the Secretary of Health and Human Services (HHS) to propose and seek comment on guidance for the Medicare Drug Price Negotiation Program and collaborate with Congress to align the treatment of small molecule drugs with biological products, citing concerns about industry investment distortions and cost increases for Medicare and its beneficiaries.[2]
Government Program Fraud, False Claims Act & Qui Tam Litigation Playbook
|May 1, 2025
|10+ Min Read
Future FCA Enforcement Expectations in Light of New Administration Priorities and 2024 Recoveries
The annual False Claims Act (FCA) recovery statistics issued by the U.S. Department of Justice for Fiscal Year 2024, coupled with the Trump administration’s focus on the elimination of waste, fraud, and abuse in government spending and apparent intentions to rely on the FCA to pursue other administration priorities, signal a likely increase in FCA investigations and actions throughout 2025 and beyond.
Competition Corner
|May 1, 2025
|2 Min Read
For companies operating in the U.S. consumer and retail space—whether in luxury goods, electronics, e-commerce, or mass retail—the current political and regulatory climate presents a shifting landscape of antitrust enforcement that’s worth watching closely.
Other Results 32 results
Site Content
What Is Anti-Bribery and Corruption?
The terms anti-bribery and anti-corruption encompass the laws, agreements, or policies aimed at stopping or punishing all forms of bribery and corruption. For example, under the Foreign Corrupt Practices Act (FCPA), it is unlawful for a U.S. person or company to offer, pay, or promise to pay money or anything of value to a foreign official for the purpose of corruptly obtaining or retaining business.
Site Content
Anti-Money Laundering (AML) refers to policies and practices that prevent, detect, and report financial crimes. The principal U.S. federal law on money laundering is the Bank Secrecy Act (BSA), also known as the Currency and Foreign Transactions Reporting Act of 1970. The BSA generally mandates financial institutions to assist in governmental investigations by keeping records of cash purchases or negotiable instruments, filing reports of cash transactions exceeding a set daily aggregate amount, and reporting suspicious activity that may hint at money laundering, tax evasion, or other criminal activities.
Law Glossary
Social media law is a developing area of the law that includes both criminal and civil aspects. Generally, it covers legal issues related to user-generated content and the online sites that host or transmit it. Some of the special legal concerns raised by social media include privacy, including the rights of both social media users and third parties (for example, when photos are posted and used online without the permission of the people depicted); defamation; advertising law; and intellectual property (IP) law. Material shared on social media can sometimes infringe on a copyright, a trademark, or other IP rights.